Touchstone
Last syncNov 1, 2026, 6:55 PM ET

ALKS

Alkermes Plc. Health Care Pharmaceutical Preparations Russell 3000
$45.34Close $7.5BMarket cap $27.20 – $55.2252-week range Nov 3, 2026Next report · before the open

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass

Cautions

  • Earnings shrinking EPS −99% year on year
  • Results soon Nov 3, 2026, in 2 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Jul 28, 2026
Off 12-month high 18%
1wk up 3.9% price change
1mo up 11.9% price change
12-month return up 47% market up 11% · its own up 33%
F-score 6 / 9 Mixed
Altman Z 7.93 Low risk
P/E 31.1× price / earnings
PEG — P/E / EPS growth
P/B 4.1× price / book
Earnings yield up 3.6% EBIT / enterprise value
Cheaper than 56% of the market · around average
Revenue growth down 5% year on year
EPS growth down 99% latest quarter · +301 pts
Sales growth up 27% latest quarter · -1 pts
ROE up 15% return on equity
Free cash margin up 33% $480.3M FCF
D/E 0.00 long-term debt / equity
Net debt / EBITDA -1.4× net cash
Interest cover —EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • issued more shares
  • assets working less efficiently
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • reduced long-term debt
  • short-term liquidity improved
  • gross margin widened

Repair signals

  • Gross margin 84.2% → 86.7%

Trade setup

ATR% 3.2% $1.47 a day · 2×ATR $42.40
RS 76 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.6× vs 50-day average
Up/down volume 0.96 50 sessions
Implied move — no option chain · report Nov 3, 2026
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Shareholders diluted The share count rose 2.1% over the year, from 162m to 166m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
  • Revenue shrinking Revenue fell 5.2% over the year, from $1.6B to $1.5B.
Last reported Jul 28, 2026

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.5B -5% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.0B FY2021 · $1.2B FY2022 · $1.1B FY2023 · $1.7B FY2024 · $1.6B FY2025 · $1.5B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $241.7M -34% on FY2024
-$200M $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$110.9M FY2021 · -$48.2M FY2022 · -$158.3M FY2023 · $355.8M FY2024 · $367.1M FY2025 · $241.7M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $480.3M +18% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $40.6M FY2021 · $73.7M FY2022 · -$17.2M FY2023 · $353.3M FY2024 · $405.6M FY2025 · $480.3M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 87%
  • Net 16%
  • Free cash 33%
-20% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 83% · Net -11% · Free cash 4% FY2021 · Gross 83% · Net -4% · Free cash 6% FY2022 · Gross 80% · Net -14% · Free cash -2% FY2023 · Gross 85% · Net 21% · Free cash 21% FY2024 · Gross 84% · Net 24% · Free cash 26% FY2025 · Gross 87% · Net 16% · Free cash 33%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $388.6M net cash
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $273.0M · Long-term debt $272.1M FY2021 · Cash $337.5M · Long-term debt $292.8M FY2022 · Cash $292.5M · Long-term debt $290.3M FY2023 · Cash $457.5M · Long-term debt $287.7M FY2024 · Cash $291.1M FY2025 · Cash $388.6M · Long-term debt $0
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 165.61m +4.0% since FY2020
166.98m 159.16m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 159.16m FY2021 · 161.94m FY2022 · 164.38m FY2023 · 166.98m FY2024 · 162.18m FY2025 · 165.61m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.0B $1.2B $1.1B $1.7B $1.6B $1.5B
Gross margin 83% 83% 80% 85% 84% 87%
Operating income -$112.4M $97.7M -$6.1M $414.1M $420.6M $254.0M
Net income -$110.9M -$48.2M -$158.3M $355.8M $367.1M $241.7M
Net margin -11% -4% -14% 21% 24% 16%
Earnings per share -$0.70 -$0.29 -$0.97 $2.10 $2.17 $1.43
Free cash flow $40.6M $73.7M -$17.2M $353.3M $405.6M $480.3M
Free cash margin 4% 6% -2% 21% 26% 33%
Cash $273.0M $337.5M $292.5M $457.5M $291.1M $388.6M
Long-term debt $272.1M $292.8M $290.3M $287.7M — $0
Shareholders' equity $1.1B $1.1B $1.0B $1.2B $1.5B $1.8B
Shares outstanding 159.16m 161.94m 164.38m 166.98m 162.18m 165.61m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Jul 28, 2026 Quarterly ↗ Jun 30, 2026 28d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Feb 25, 2026 Annual ↗ Dec 31, 2025 56d
Oct 28, 2025 Quarterly ↗ Sep 30, 2025 28d
Jul 29, 2025 Quarterly ↗ Jun 30, 2025 29d
May 1, 2025 Quarterly ↗ Mar 31, 2025 31d
Feb 12, 2025 Annual ↗ Dec 31, 2024 43d
Oct 24, 2024 Quarterly ↗ Sep 30, 2024 24d
Jul 24, 2024 Quarterly ↗ Jun 30, 2024 24d
May 1, 2024 Quarterly ↗ Mar 31, 2024 31d
Feb 21, 2024 Annual ↗ Dec 31, 2023 52d
Oct 25, 2023 Quarterly ↗ Sep 30, 2023 25d

Current reports

FiledDisclosed
Sep 21, 2026 Regulation FD · Other events ↗
Sep 16, 2026 Director or officer change · Regulation FD ↗
Aug 12, 2026 Material agreement ↗
Jul 28, 2026 Results ↗
Jul 8, 2026 Agreement ended ↗
Jun 15, 2026 Regulation FD · Other events ↗
May 20, 2026 Director or officer change · Shareholder vote ↗
May 12, 2026 Regulation FD · Other events ↗
May 5, 2026 Results ↗
Feb 25, 2026 Director or officer change · Regulation FD ↗
Feb 25, 2026 Results ↗
Feb 12, 2026 Material agreement · Agreement ended · Acquisition or disposal · New obligation · Regulation FD ↗